TY - JOUR
T1 - Non-lethal congenital hypotonia due to glycogen storage disease type IV
AU - Burrow, T. Andrew
AU - Hopkin, Robert J.
AU - Bove, Kevin E.
AU - Miles, Lili
AU - Wong, Brenda L.
AU - Choudhary, Arabinda
AU - Bali, Deeksha
AU - Li, Sing Chung
AU - Chen, Yuan Tsong
PY - 2006/4/15
Y1 - 2006/4/15
N2 - Glycogen storage disease type IV (GSD-IV) is an autosomal recessive genetic disorder due to a deficiency in the activity of the glycogen branching enzyme (GBE). A deficiency in GBE activity results in the accumulation of glycogen with fewer branching points and long, unbranched outer chains. The disorder results in a variable phenotype, including musculoskeletal, cardiac, neurological, and hepatic involvement, alone or in continuum, which can be identified at any stage of life. The classic form of GSD-IV is a hepatic presentation, which presents in the first 18 months of life with failure to thrive, hepatomegaly, and cirrhosis that progresses to liver failure, resulting in death by age 5 years. A severe congenital musculoskeletal phenotype with death in the neonatal period has also been described. We report an unusual case of congenital musculoskeletal presentation of GSD-IV with stable congenital hypotonia, gross motor delay, and severe fibro-fatty replacement of the musculature, but no hepatic or cardiac involvement. Molecular analysis revealed two novel missense mutations with amino acid changes in the GBE gene (Q236H and R262C), which may account for the mild phenotype.
AB - Glycogen storage disease type IV (GSD-IV) is an autosomal recessive genetic disorder due to a deficiency in the activity of the glycogen branching enzyme (GBE). A deficiency in GBE activity results in the accumulation of glycogen with fewer branching points and long, unbranched outer chains. The disorder results in a variable phenotype, including musculoskeletal, cardiac, neurological, and hepatic involvement, alone or in continuum, which can be identified at any stage of life. The classic form of GSD-IV is a hepatic presentation, which presents in the first 18 months of life with failure to thrive, hepatomegaly, and cirrhosis that progresses to liver failure, resulting in death by age 5 years. A severe congenital musculoskeletal phenotype with death in the neonatal period has also been described. We report an unusual case of congenital musculoskeletal presentation of GSD-IV with stable congenital hypotonia, gross motor delay, and severe fibro-fatty replacement of the musculature, but no hepatic or cardiac involvement. Molecular analysis revealed two novel missense mutations with amino acid changes in the GBE gene (Q236H and R262C), which may account for the mild phenotype.
KW - Andersen disease
KW - Congenital myopathy
KW - Glycogen branching enzyme (GBE)
KW - Glycogen storage disease (GSD)
UR - http://www.scopus.com/inward/record.url?scp=33645574894&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33645574894&partnerID=8YFLogxK
U2 - 10.1002/ajmg.a.31166
DO - 10.1002/ajmg.a.31166
M3 - Article
C2 - 16528737
AN - SCOPUS:33645574894
SN - 1552-4825
VL - 140 A
SP - 878
EP - 882
JO - American Journal of Medical Genetics
JF - American Journal of Medical Genetics
IS - 8
ER -